Tag: Pharmaceutical industry
Novartis offers 2.7 billion euros for Munich biotech company Morphosys – Economy
The Swiss pharmaceutical company Novartis is reaching out to the biotech company Morphosys. The Swiss are spending 2.7 billion euros on this. Novartis is particularly interested in the promising pelabresib…
Thanks to the weight loss injection, the economy is flying high
The Danish pharmaceutical company Novo Nordisk continues to soar thanks to the popular weight loss injection Wegovy. After a jump in sales and profits of more than 30 percent last…
Bayer plans major staff cuts – economy
Bayer boss Bill Anderson has never made a secret about what the ideal employee looks like for him and what structure a company should have. Employees should think like entrepreneurs…
Miele: How the company’s unknown division should grow – economics
When most people think of the Miele brand, they think of stoves and vacuum cleaners, washing machines and dishwashers – household helpers. But the Gütersloh family business also has its…
Lack of medication: "Nowhere is the situation as dramatic as in Germany"
An important HIV drug is in short supply. Experts fear that more people will become infected again as a result. And the problem is partly homemade. source site
Faced with the shortage, the drug safety agency announces deliveries
It should be much easier to find amoxicillin very soon. The Medicines Safety Agency (ANSM) wanted to reassure Tuesday in the face of supply tensions for this very common antibiotic,…
What the weight loss injection is good for – health
Of course, Matthias Blüher has known for a long time that being overweight causes problems for people and that there is a great desire to lose it. As an expert…
Bayer: What problems the new boss Bill Anderson has to contend with – economy
Investors had high hopes that the American Bill Anderson would be able to get the company back on track. Now analysts are talking about the “perfect negative storm.” No CEO…
Agricultural and pharmaceutical industries: The many construction sites of the new Bayer boss
Investors had high hopes that the American Bill Anderson would be able to get the company back on track. Now analysts are talking about the “perfect negative storm.” source site
Asundexian development canceled: A flop that costs Bayer billions – Economy
The hope at Bayer was great, but now the disappointment is even more so. The flop of an important new drug in development weighed heavily on the shares of the…